PAI
BMY.RT

Pittenger & Anderson Inc’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Pittenger & Anderson Inc’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,925
Closed -$1K – 416
2020
Q4 		$1K Hold
1,925
– – ﹤0.01% 374
2020
Q3 		$4K Hold
1,925
– – ﹤0.01% 330
2020
Q2 		$7K Hold
1,925
– – ﹤0.01% 312
2020
Q1 		$7K Hold
1,925
– – ﹤0.01% 303
2019
Q4 		$6K Buy
+1,925
New +$5.01K ﹤0.01% 333

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Pittenger & Anderson Inc's BMY.RT Position: Q1 2021 in Review

Pittenger & Anderson Inc sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,925 shares — an estimated $1K sold.

Pittenger & Anderson Inc first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $7K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Pittenger & Anderson Inc reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 1,925 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1K.
  • Pittenger & Anderson Inc first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Pittenger & Anderson Inc's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $7K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Pittenger & Anderson Inc's 13F filing for Q1 2021, filed 12 May 2021.